Torrent Pharmaceuticals Limited Stock Current Valuation
| TORNTPHARM | 3,324 121.25 3.79% |
Valuation analysis of Torrent Pharmaceuticals helps investors to measure Torrent Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, Torrent Pharmaceuticals' Other Non Cash Items is increasing as compared to previous years. The Torrent Pharmaceuticals' current Total Cash From Operating Activities is estimated to increase to about 34.3 B, while Cash is projected to decrease to under 4.8 B. Fundamental drivers impacting Torrent Pharmaceuticals' valuation include:
Price Book 14.9928 | Enterprise Value 1.1 T | Enterprise Value Ebitda 31.0606 | Price Sales 10.0238 | Forward PE 56.4972 |
Fairly Valued
Today
Please note that Torrent Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Torrent Pharmaceuticals is based on 3 months time horizon. Increasing Torrent Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Torrent Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Torrent Stock. However, Torrent Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3324.2 | Real 3326.16 | Hype 3328.32 | Naive 3405.08 |
The intrinsic value of Torrent Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Torrent Pharmaceuticals' stock price.
Estimating the potential upside or downside of Torrent Pharmaceuticals Limited helps investors to forecast how Torrent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Torrent Pharmaceuticals more accurately as focusing exclusively on Torrent Pharmaceuticals' fundamentals will not take into account other important factors: Torrent Pharmaceuticals Limited Company Current Valuation Analysis
Torrent Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Torrent Pharmaceuticals Current Valuation | 1.14 T |
Most of Torrent Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Torrent Pharmaceuticals Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Torrent Pharmaceuticals Limited has a Current Valuation of 1.14 T. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Torrent Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Torrent Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Torrent Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Torrent Pharmaceuticals by comparing valuation metrics of similar companies.Torrent Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Torrent Fundamentals
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.14 T | ||||
| Shares Outstanding | 338.44 M | ||||
| Shares Owned By Insiders | 69.74 % | ||||
| Shares Owned By Institutions | 14.09 % | ||||
| Price To Book | 14.99 X | ||||
| Price To Sales | 10.02 X | ||||
| Revenue | 106.05 B | ||||
| Gross Profit | 60.66 B | ||||
| EBITDA | 35.01 B | ||||
| Net Income | 16.56 B | ||||
| Cash And Equivalents | 379.8 M | ||||
| Total Debt | 40.22 B | ||||
| Book Value Per Share | 221.48 X | ||||
| Cash Flow From Operations | 32.66 B | ||||
| Earnings Per Share | 53.19 X | ||||
| Target Price | 3586.67 | ||||
| Number Of Employees | 15.72 K | ||||
| Beta | 0.26 | ||||
| Market Capitalization | 1.13 T | ||||
| Total Asset | 150.61 B | ||||
| Retained Earnings | 39.42 B | ||||
| Working Capital | 1.85 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 150.61 B |
About Torrent Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Torrent Pharmaceuticals Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Torrent Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Torrent Pharmaceuticals Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Torrent Stock
Torrent Pharmaceuticals financial ratios help investors to determine whether Torrent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Torrent with respect to the benefits of owning Torrent Pharmaceuticals security.